Literature DB >> 14724808

Mortality in inflammatory bowel disease: a population-based cohort study.

Tim Card1, Richard Hubbard, Richard F A Logan.   

Abstract

BACKGROUND & AIMS: There is no consensus regarding any increase in mortality with inflammatory bowel disease (IBD). In general, previous studies were not contemporary and were unable to correct for likely confounders. We have performed a large cohort study to examine contemporary IBD related mortality in the United Kingdom.
METHODS: We selected subjects within the General Practice Research Database with a coded diagnosis of inflammatory bowel disease and up to 5 matched controls for each. We derived the date of recorded deaths and information on smoking and a variety of medical conditions. We calculated both the absolute risk of death and the relative risk as a hazard ratio corrected for available confounders by Cox regression.
RESULTS: We included 16,550 IBD cases with 1047 deaths and 82,917 controls with 3758 deaths. The mortality rate was 17.1 per 1000 person-years overall for IBD cases and 12.3 for controls; this difference was greatest in the elderly. Conversion of these figures to hazard ratios by Cox regression gave hazard ratios of 1.54 (1.44-1.65) for all IBD, 1.44 (1.31-1.58) for ulcerative colitis (UC), and 1.73 (1.54-1.96) for Crohn's disease. The greatest hazard ratio for UC was among the 40-59-year age group (1.79 [1.42-2.27]) and for Crohn's disease among 20-39-year-olds (3.82 [2.17-6.75]).
CONCLUSIONS: IBD is associated with an overall small increase in mortality rate greatest in relative terms in younger subjects but in absolute terms in the elderly.

Entities:  

Mesh:

Year:  2003        PMID: 14724808     DOI: 10.1053/j.gastro.2003.09.029

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  42 in total

1.  Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.

Authors:  W J Sandborn; E V Loftus
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

2.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  Association of age at diagnosis and ulcerative colitis phenotype.

Authors:  Sandra M Quezada; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

4.  Current trends in inflammatory bowel disease: the natural history.

Authors:  Ebbe Langholz
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 6.  Crohn's disease: why the disparity in mortality?

Authors:  E V Loftus
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 7.  Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission.

Authors:  Douglas L Nguyen; Berkeley Limketkai; Valentina Medici; Mardeli Saire Mendoza; Lena Palmer; Matthew Bechtold
Journal:  Curr Gastroenterol Rep       Date:  2016-10

8.  Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.

Authors:  Angelica Nocerino; Alexandra Feathers; Elena Ivanina; Laura Durbin; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

9.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

10.  Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing.

Authors:  J M Otto; A F O'Doherty; P J Hennis; K Mitchell; J S Pate; J A Cooper; M P W Grocott; H E Montgomery
Journal:  Int J Colorectal Dis       Date:  2012-07-29       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.